Julie Rubinstein

Julie Rubinstein

President and Chief Operating OfficeratAdaptive Biotechnologies· In proxies 2021–2025

Pay in FY2023-55% from the year before · Adaptive Biotechnologies stock -35.9% the same year

Julie Rubinstein was paid $3.0M in FY2023 (Dec), down 55%. Adaptive Biotechnologies stock fell 35.9% that year.

Pay$100 in the stock at the end of FY20 → $8
Pay is from the Summary Compensation Table of each Adaptive Biotechnologies proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Adaptive BiotechnologiesPublic company · 5 yr
    • President and Chief Operating Officer2021 – Present · 5 yrStock in role -55%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?